Eli Lilly pauses COVID-19 antibody trial, stock slides
Companies, agencies, institutions, etc
Factset
FactSet Digital Solutions
Legal Statement
Mutual Fund
ETF
FOX News Network
LLC
FAQ
PAUSE
CORONAVIRUS
Lilly
Eli Lilly
FOX Business
the National Institute of Allergy
NIAID
the National Institutes of Health
FOX BUSINESS
the Food and Drug Administration
LY-CoV555
People
Refinitiv Lipper
Alex Azar
Johnson
Groups
No matching tags
Physical locations
No matching tags
Places
No matching tags
Locations
Eli
U.S.
enrollment."The
Events
No matching tags
Summary
FAQ - Updated Privacy PolicyHealth and Human Services Secretary Alex Azar on coronavirus vaccine clinical trials.Enrollment for Eli Lilly's late-stage trial of its monoclonal antibody treatment is being put on hold over potential safety concerns following a recommendation from U.S. health regulators.Continue Reading BelowJOHNSON & JOHNSON POSTS STRONG THIRD QUARTER EARNINGS AFTER PAUSE IN CORONAVIRUS VACCINE STUDY“Safety is of the utmost importance to Lilly," an Eli Lilly spokesperson told FOX Business in a statement Tuesday.
As said here by Fox News